Prestige Consumer Healthcare Inc (NYSE:PBH) has been given a consensus rating of “Hold” by the seven research firms that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has given a buy recommendation to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $65.68.
Shares of PBH traded down $0.40 during mid-day trading on Tuesday, hitting $37.43. 1,914 shares of the company traded hands, compared to its average volume of 254,760. The company has a debt-to-equity ratio of 1.60, a quick ratio of 1.22 and a current ratio of 2.08. Prestige Consumer Healthcare has a 1 year low of $26.25 and a 1 year high of $39.39. The stock has a market cap of $1.90 billion, a price-to-earnings ratio of 13.46, a P/E/G ratio of 2.06 and a beta of 0.91. The stock has a 50-day moving average price of $36.69 and a two-hundred day moving average price of $33.38.
Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings results on Thursday, October 31st. The company reported $0.68 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.02. Prestige Consumer Healthcare had a positive return on equity of 12.68% and a negative net margin of 3.56%. The firm had revenue of $238.07 million for the quarter, compared to the consensus estimate of $237.17 million. During the same period last year, the business posted $0.65 EPS. The company’s revenue for the quarter was down .5% on a year-over-year basis. On average, analysts forecast that Prestige Consumer Healthcare will post 2.82 EPS for the current year.
Several large investors have recently bought and sold shares of the company. Maverick Capital Ltd. increased its holdings in Prestige Consumer Healthcare by 159.0% in the 3rd quarter. Maverick Capital Ltd. now owns 197,352 shares of the company’s stock worth $6,846,000 after acquiring an additional 121,162 shares in the last quarter. Point72 Asset Management L.P. bought a new stake in shares of Prestige Consumer Healthcare during the 3rd quarter valued at $108,000. Parametric Portfolio Associates LLC raised its position in shares of Prestige Consumer Healthcare by 13.2% during the 3rd quarter. Parametric Portfolio Associates LLC now owns 409,359 shares of the company’s stock valued at $14,201,000 after purchasing an additional 47,672 shares during the period. Ancora Advisors LLC raised its position in shares of Prestige Consumer Healthcare by 26.2% during the 3rd quarter. Ancora Advisors LLC now owns 19,460 shares of the company’s stock valued at $675,000 after purchasing an additional 4,040 shares during the period. Finally, Stifel Financial Corp lifted its stake in shares of Prestige Consumer Healthcare by 16.1% during the 3rd quarter. Stifel Financial Corp now owns 7,820 shares of the company’s stock valued at $271,000 after buying an additional 1,084 shares in the last quarter.
Prestige Consumer Healthcare Company Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Recommended Story: What is a blue-chip stock?
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.